2.5. Metformin and FOXA1 Deletion Enhance Tamoxifen-Mediated Tumor Cell Growth Inhibition in Hormone-Receptor-Positive Breast Cancer (HR+ BC) Cells. Here, FOXA1 is linked to breast carcinoma.